IGHE and asthma: Biologic therapies (such as anti-IgE, anti-IL-5 monoclonal antibodies, IL-4α receptor antagonist, and anti-thymic stromal lymphopoietin) could be promising therapeutic options for AERD patients given their effectiveness in nasal polyposis and asthma (108).